Senzime AB (publ) announced another major US hospital system deal. A New York metropolitan area-based university hospital group has placed an initial order for 36 TetraGraph systems with additional orders in pipeline for 2024. The new 2023 US and European clinical guidelines recommending quantitative neuromuscular monitoring during surgery continue to be implemented in clinical practice across academic, university, regional and local hospitals.

TetraGraph is a quantitative neuromuscular monitoring system that is used by anesthesiologists at hundreds of leading hospitals across the globe to help improve patient safety during and after surgery. TetraGraph helps anesthesiologists to accurately secure the right dose of neuromuscular blocking drugs and their antagonists, as well as indicates when it is safe to allow patients to breathe on their own again after surgery.